In this context, seven Spanish laboratories belonging to the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), working in the diagnostic and research of mitochondrial diseases, started a coordinated program to establish common protocols for MRC enzyme determinations in all laboratories. Here, CD200 is linked to inborn mitochondrial metabolism disorder.